/
CD-EPI.CENTER CD-EPI.CENTER

CD-EPI.CENTER - PowerPoint Presentation

kittie-lecroy
kittie-lecroy . @kittie-lecroy
Follow
374 views
Uploaded On 2017-11-13

CD-EPI.CENTER - PPT Presentation

WHEN THE ENVIRONMENT MEETS THE GENETIC Medicel Meeting Palermo April 26th 2014 WHAT WE KNOW CD prevalence is increasing at unexpected rate in the last 20 years ID: 605261

factors risk genes epigenetic risk factors epigenetic genes cohort expression methylation environmental gene dna regulation histone families study genomic

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document "CD-EPI.CENTER" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

Slide1

CD-EPI.CENTER

WHEN THE ENVIRONMENT MEETS THE GENETIC!

Medicel

Meeting

Palermo –

April

26th 2014Slide2

WHAT WE KNOW:

CD prevalence

is

increasing at

unexpected rate in the last 20

years

:

a series of environmental factors do influence the phenotype of CD.

Several reports point to prenatal and early life factors as a possible contribution to the epigenetic expression of genes:

Pre-

conceptional

status:

Offspring

of

affected

fathers

have

an

higher

risk

to

develop

CD

, The Carter

effect

.

Pregnancy:

Ab

anti-

Tgase

in placenta

trophoblasts

may be associated to

unfavourable

outcome of

pregnancy.Women

with untreated CD, but not with treated CD has higher risk of SGA infants.

Season of birth:

Summer birth was associated with a small increased risk of later CD

Mode of delivery:

An association between elective cesarean delivery and later CD was reported

Perinatal

events

: Breast

Feeding

appers

to

delay

the

onset

of

symptoms

of

CD

,

A correlation with exposure to neonatal infections (and being small for gestational age was also reported. Slide3

EPIGENETICS

Persistent changes in tissue structure and function, that are induced during the development of the embryo and fetus,

play an important role in determining the risk of non communicable diseases

.

The process that underlies the induction of differential risk of disease by variation in the prenatal environment reflects environmental cues acting through developmental plasticity

, which generate a range of genotypes from a single genome.

Gene-environment interactions are centrally involved in our health

but also in the susceptibility to diseases and these influences are likely to be mediated, to a large extent,

via epigenetic regulatory phenomena

. Recent findings show that altered epigenetic regulation of specific genes is central to the process by which different phenotypes are generated and hence differential risk of disease rises.Slide4

DNA

methylation

Histone

modifications (PTMs)

MicroRNA

regulation

EPIGENETIC MECHANISMS

The missing heredity

od

CD could be explained by the action of epigenetic mechanisms and by their interaction between genes and environmental risk factors.Epigenetic modifications are heritable changes in gene expression without changes in DNA sequenceSlide5

DNA METHYLATION

DNA methylation has been implicated in the control of several cellular processes including differentiation, gene regulation, development, genomic imprinting and X-chromosome inactivation. Methylated

cytosine residues at

CpG

dinucleotides are commonly associated with gene repression; conversely, strategic loss of

methylation

during development could lead to activation of lineage-specific genes.

The overall effect of genome-wide de-

methylation

is to produce pluripotent cells in which all genes are potentially transcriptionally active. Loss of pluripotency with cell differentiation and the establishment of adult tissue function are dependent by changes in the methylation status of individual gene promoters at different times in development Slide6

HISTONE MODIFICATIONS (PTMS)

Include acetylation, methylation,

phosphorylation

, ADP-ribosylation

, ubiquitination

, and

biotinylation

are in general, dynamic, highly regulated, and transient, so as to adapt to physiological changes in the cell.

Although chromatin modifications have been divided into those that correlate with activation and those that correlate with repression of transcription, the truth is likely to be that any given modification can activate or repress genes depending on the context.

The research on the impact of histone modification placental gene expression may allow to gain a better understanding of important phenomena, such as tolerance maternal-fetal, and placental growth and differentiation, and try to explain the effects that environmental factors have on these processes.Slide7

MICRO-RNA REGULATION

One of the most studied mechanisms of gene regulation in these years is represented by micro-RNAs (miRNAs). MicroRNAs

are important regulators of gene expression therefore, it is easy to conceive that protein

overexpression resulting from defective

miRNA-based mRNA regulation may compromise normal cell function and cause genetic diseases.

Qualitative and the quantitative expressions of

miRNAs

, are expected to exert a profound regulatory influence on the

transcriptome

, thus the accurate profiling of miRNA expression represents an important tool to investigate physiological and pathological states.Slide8

WHAT WE PLAN TO DO:

Aim of this project is to evaluate the combined influences of genetic, epigenetic and environmental factors in the development of CD in at risk families.

The experimental design involves the articulation in the following points:

estimate and validate epidemiological and individual risk factorscorrelate this factors with the outcome and the genomic profile of the cases

correlate the outcome and the risk factors (including genomic) with eventual epigenetic profiles of cases and non-cases.Slide9

How

we will perform the

study

.... RECRUITMENT!

NEOCEL

cohort

:

300 newborns from at risk families with one

proband followed for 5 years, with known outcome.From this cohort we have stored:

sera and DNA from

probands

, fathers and mothers,

cord blood, and PBL from the newborns (several samples longitudinally over time). Slide10

How

we will perform the

study

.... RECRUITMENT!

Perspective new cohort (CD-EPI.CENTER):

500 families

with one celiac

proband

at

moment of a new pregnancyIn 3 years 250-300 newborns are expected. For this new cohort we will collect:PBL from parents and probands before conception (500 samples)Samples of placenta (250-300 samples)

Umbilical cord (250-300 samples)Slide11

How

we will perform the

study

.... EXPERIMENTAL DESIGN!

We propose to study the mechanisms of epigenetic regulation in the

64 genes associated with CD

, and in the additional genes regulated by the main pathways involved in CD pathogenesis.

We

will investigate: the DNA methylation status of candidates genes and the transmission inside the familythe expression levels and activities of histone-modifying enzymes

the genomic distribution of particular

histone

PTMs

the

miRNA

expression pattern in PBL and the transmission inside the family

the possible variations in epigenetic pattern in relationship to the risk factors listed aboveSlide12

The PHASE 1: ESTIMATE OF RISK FACTORS

Our first cohort is the Regional Registry of Coeliac Disease (8000

Celiacs), we will analyze, in a case control design,

the possible correlation between onset of CD and the following risk factors

:

Sex

First Degree Affected

Season of Birth

Phenotype and associated conditionSlide13

300 Infants :Followed since birth, with know outcome at 5 years

to validate the previous risk factors, adding the estimate of the following environmental factors:PregnancyOutcome of delivery

Birth Weight

Perinatal

events

Breast feeding

Early infectious events

We plan to analyze 20 families in which the child has developed celiac disease and compare the data with 20 families in which no son developed celiac disease.

In this cohort we will investigate:

the status of DNA methylation of candidates genes and the transmission inside the family

the possible variations in DNA

methylation

patter in relationship to the risk factors listed above

the expression levels and activities of

histone

-modifying enzymes

the genomic distribution of particular

histone

PTMs

The PHASE 2: NEOCEL COHORTSlide14

The PHASE 3: CD-EPICENTER COHORT

Also for this cohort we will estimate the environmental factors listed above.We aim to perform a comprehensive analysis to estimate the Pre-Natal risk factors and genomic and epigenetic profiles in a subsample with higher risk factors

We plan to analyze in at least 48 families with the more significant risk factors, suggested by the analysis performed in the previous phases of the study.

The comparative epigenetic analysis of the placenta might

provide a first evidence of the direct action of environmental

factors in the modulation of genetic expression pattern in CD

.Slide15

CONCLUDING…

We demonstrated that the gene expression analysis of candidate genes, allow to discriminate between CD and controls. Now, our idea is to understand if these differences may be due to epigenetic mechanisms, and if they can be triggered by environmental factors

.

Inherited epigenetic changes have been proposed as an explanation for the ‘‘missing heritability,’’ meaning inherited causes of risk of complex genetic diseases as CD that have not yet been identified in GWAS

.

The prospective CD-EPICENTER cohort enrolled in this study will contribute to understand the weight of risk factors in a population of CD cases which is not fully homogeneous.